Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Nature Chemical Biology
|
November 8, 2016
Non-classical transpeptidases yield insight into new antibacterials
Pankaj Kumar, Amit Kaushik, Evan P Lloyd, et al.
Plos One
|
October 31, 2014
Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein
Reem R Al Olaby, Laurence Cocquerel, Adam Zemla, et al.
ACS Medicinal Chemistry Letters
|
February 18, 2026
Design of a Targeted Covalent Probe to Interrogate the DNA Polymerase Activity of Polθ
Monica Bubenik, Pavel Mader, Stephen Orlicky, et al.
ACS Infectious Diseases
|
August 3, 2021
Bayesian Modeling and Intrabacterial Drug Metabolism Applied to Drug-Resistant <i>Staphylococcus aureus</i>
Jimmy S Patel, Javiera Norambuena, Hassan Al-Tameemi, et al.
Journal of Medicinal Chemistry
|
July 26, 2022
Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306
Janek Szychowski, Robert Papp, Evelyne Dietrich, et al.
Journal of Chemical Information and Modeling
|
October 14, 2022
Discovery of New Zika Protease and Polymerase Inhibitors through the Open Science Collaboration Project OpenZika
Melina Mottin, Bruna Katiele de Paula Sousa, Nathalya Cristina de Moraes Roso Mesquita, et al.
Mbio
|
December 20, 2018
Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasA
Pradeep Kumar, Glenn C Capodagli, Divya Awasthi, et al.
Journal of Medicinal Chemistry
|
May 16, 2025
Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor
Frédéric Vallée, Matias Casás-Selves, Monica Bubenik, et al.
Journal of Medicinal Chemistry
|
September 8, 2025
The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ ATPase Inhibitor
Philippe Mochirian, Robert Papp, Marie-Claude Mathieu, et al.
Journal of Medicinal Chemistry
|
September 20, 2022
Identification of <b>RP-6685</b>, an Orally Bioavailable Compound that Inhibits the DNA Polymerase Activity of Polθ
Monica Bubenik, Pavel Mader, Philippe Mochirian, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Nature Chemical Biology
|
November 8, 2016
Non-classical transpeptidases yield insight into new antibacterials
Pankaj Kumar, Amit Kaushik, Evan P Lloyd, et al.
Plos One
|
October 31, 2014
Identification of a novel drug lead that inhibits HCV infection and cell-to-cell transmission by targeting the HCV E2 glycoprotein
Reem R Al Olaby, Laurence Cocquerel, Adam Zemla, et al.
ACS Medicinal Chemistry Letters
|
February 18, 2026
Design of a Targeted Covalent Probe to Interrogate the DNA Polymerase Activity of Polθ
Monica Bubenik, Pavel Mader, Stephen Orlicky, et al.
ACS Infectious Diseases
|
August 3, 2021
Bayesian Modeling and Intrabacterial Drug Metabolism Applied to Drug-Resistant <i>Staphylococcus aureus</i>
Jimmy S Patel, Javiera Norambuena, Hassan Al-Tameemi, et al.
Journal of Medicinal Chemistry
|
July 26, 2022
Discovery of an Orally Bioavailable and Selective PKMYT1 Inhibitor, RP-6306
Janek Szychowski, Robert Papp, Evelyne Dietrich, et al.
Journal of Chemical Information and Modeling
|
October 14, 2022
Discovery of New Zika Protease and Polymerase Inhibitors through the Open Science Collaboration Project OpenZika
Melina Mottin, Bruna Katiele de Paula Sousa, Nathalya Cristina de Moraes Roso Mesquita, et al.
Mbio
|
December 20, 2018
Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasA
Pradeep Kumar, Glenn C Capodagli, Divya Awasthi, et al.
Journal of Medicinal Chemistry
|
May 16, 2025
Discovery of RP-1664: A First-in-Class Orally Bioavailable, Selective PLK4 Inhibitor
Frédéric Vallée, Matias Casás-Selves, Monica Bubenik, et al.
Journal of Medicinal Chemistry
|
September 8, 2025
The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ ATPase Inhibitor
Philippe Mochirian, Robert Papp, Marie-Claude Mathieu, et al.
Journal of Medicinal Chemistry
|
September 20, 2022
Identification of <b>RP-6685</b>, an Orally Bioavailable Compound that Inhibits the DNA Polymerase Activity of Polθ
Monica Bubenik, Pavel Mader, Philippe Mochirian, et al.
Page
of 4